Clinical Impact of Next-Generation Sequencing in KRAS-Mutated Non-Small Cell Lung Cancer Patients: a Single-Center Experience
Journal of Thoracic Oncology(2023)
摘要
The use of next-generation sequencing (NGS) in patients with non-small cell lung cancer (NSCLC) has allowed for the efficient use of biopsy specimens for the detection of driver mutations, to inform prognosis and decision-making regarding the use of immunotherapy and targeted therapies. Little is known about the clinical utility of NGS in KRAS-mutated NSCLC patients.
更多查看译文
关键词
Non-small cell lung cancer,Driver mutation,Next-generation sequencing
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要